Dr. García-Pavia is a Consultant cardiologist at the Department of Cardiology of Hospital Universitario Puerta de Hierro in Madrid, Spain. There he is in charge of the Inherited Cardiac Diseases and Heart Failure Unit. The Unit is designed as national reference unit (CSUR) for inherited cardiovascular diseases by the Spanish Ministry of Health and also acts as a European reference center for rare cardiovascular diseases after its designation by the European Comission.

His areas of research include heart failure, amyloidosis and cardiomyopathies. After finishing his training in Cardiology in Madrid, Dr Garcia-Pavia completed a clinical research fellowship at the Inherited Cardiovascular Diseases Unit at The Heart Hospital (University College of London) in London, UK. Previously he had undertaken short stays as research fellow in basic research labs focused in genetics at the University of Chicago, Complutense University and Autonoma University.

Dr Garcia-Pavia is the leader of the 2021 ESC position paper on diagnosis and treatment of cardiac amyloidosis and serves in the steering committee of several ongoing clinical trials in TTR cardiac amyloidosis and genetic cardiomyopathies. He is also former member of ESC Council on Basic Research, former member of the Nucleus of ESC working group on myocardial and pericardial diseases, and former president of Spanish Society of Cardiology’s working group on inherited cardiac diseases. He has published >160 articles in peer-reviewed journals including European Heart Journal, J Am Coll Cardiol, Circulation, Nature Communications, Nature Medicine and The Lancet.